Mission and Vision
The VIB-UGent Center for Medical Biotechnology (CMB) is VIB’s main center of biomolecular analytics and biopharmaceutical engineering research, with a key focus on protein technology.
CMB researchers operate within the Center’s overall vision of innovating the analysis and engineering of biomolecular systems to investigate and alleviate human disease.
CMB’s strategic approach is technological innovation-driven, inspired by solving selected biomedical research, diagnostics and therapeutic challenges for which we believe that our particular technological innovations could have the largest impact.
CMB’s mission is to push the boundaries of protein-focused biomolecular and bioinformatics research and engineering technologies, to translate our novel technologies and insights to widely applicable research tools, vaccines, diagnostics and biopharmaceuticals, to educate and train the next generation of medical biotechnology researchers and to inform the public on the impact of biotechnology on human health.
Funding and partners
CMB research is supported by Ghent University, the Flemish government and many (inter)national funding bodies.
VIB-UGent for Medical Biotechnology
UGent-VIB Research Building FSVMII
Technologiepark - Zwijnaarde 75
Science Director: Nico Callewaert